Advanced company searchLink opens in new window

ADVANZ PHARMA GENERICS (UK) LIMITED

Company number 02760679

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
17 Aug 2023 PSC05 Change of details for Mercury Pharma Group Limited as a person with significant control on 1 August 2023
03 Aug 2023 AA Full accounts made up to 31 December 2022
02 Aug 2023 CH01 Director's details changed for Mr Andreas Stickler on 31 July 2023
01 Aug 2023 AD01 Registered office address changed from Capital House 85 King William Street London EC4N 7BL to Dashwood House 69 Old Broad Street London EC2M 1QS on 1 August 2023
27 Jul 2023 CH04 Secretary's details changed for Tmf Corporate Administration Services Limited on 24 July 2023
26 Jul 2023 CS01 Confirmation statement made on 7 July 2023 with no updates
21 Jul 2023 CH01 Director's details changed for Mr Vikram Laxman Kamath on 1 October 2022
30 Sep 2022 AA Full accounts made up to 31 December 2021
15 Jul 2022 CS01 Confirmation statement made on 7 July 2022 with no updates
28 Mar 2022 AP04 Appointment of Tmf Corporate Administration Services Limited as a secretary on 16 March 2022
28 Mar 2022 TM02 Termination of appointment of Robert Sully as a secretary on 16 March 2022
02 Feb 2022 AP01 Appointment of Mr Andreas Stickler as a director on 21 January 2022
01 Feb 2022 TM01 Termination of appointment of Adeel Ahmad as a director on 31 January 2022
26 Jan 2022 TM01 Termination of appointment of Graeme Neville Duncan as a director on 12 January 2022
19 Aug 2021 AA Full accounts made up to 31 December 2020
12 Aug 2021 MR01 Registration of charge 027606790011, created on 5 August 2021
21 Jul 2021 CS01 Confirmation statement made on 7 July 2021 with no updates
01 Jul 2021 PSC02 Notification of Mercury Pharma Group Limited as a person with significant control on 1 June 2021
30 Jun 2021 PSC07 Cessation of The Blackstone Group Inc. as a person with significant control on 1 June 2021
02 Jun 2021 MR04 Satisfaction of charge 027606790009 in full
02 Jun 2021 MR04 Satisfaction of charge 027606790010 in full
06 Jan 2021 PSC02 Notification of The Blackstone Group Inc. as a person with significant control on 27 March 2020
06 Jan 2021 PSC07 Cessation of Mercury Pharma Group Limited as a person with significant control on 27 March 2020
20 Aug 2020 AA Full accounts made up to 31 December 2019
17 Jul 2020 CS01 Confirmation statement made on 7 July 2020 with no updates